R97.1 可计费的具体编码 Elevated cancer antigen 125 [CA 125]
ICD-10-CM R97.1 identifies “Elevated cancer antigen 125 [CA 125]” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
章节 18: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
编码说明
无额外说明。
上级编码说明
章节 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)
Excludes 24
Note9
- This chapter includes symptoms, signs, abnormal results of clinical or other investigative procedures, and ill-defined conditions regarding which no diagnosis classifiable elsewhere is recorded.
- Signs and symptoms that point rather definitely to a given diagnosis have been assigned to a category in other chapters of the classification. In general, categories in this chapter include the less well-defined conditions and symptoms that, without the necessary study of the case to establish a final diagnosis, point perhaps equally to two or more diseases or to two or more systems of the body. Practically all categories in the chapter could be designated 'not otherwise specified', 'unknown etiology' or 'transient'. The Alphabetical Index should be consulted to determine which symptoms and signs are to be allocated here and which to other chapters. The residual subcategories, numbered .8, are generally provided for other relevant symptoms that cannot be allocated elsewhere in the classification.
- The conditions and signs or symptoms included in categories R00-R94 consist of:
- (a) cases for which no more specific diagnosis can be made even after all the facts bearing on the case have been investigated;
- (b) signs or symptoms existing at the time of initial encounter that proved to be transient and whose causes could not be determined;
- (c) provisional diagnosis in a patient who failed to return for further investigation or care;
- (d) cases referred elsewhere for investigation or treatment before the diagnosis was made;
- (e) cases in which a more precise diagnosis was not available for any other reason;
- (f) certain symptoms, for which supplementary information is provided, that represent important problems in medical care in their own right.
R97 · Abnormal tumor markers
Inclusion terms2
- Elevated tumor associated antigens [TAA]
- Elevated tumor specific antigens [TSA]
官方索引引用
官方索引引用 (1)
Elevated, elevation (1)
历史
编码历史
自首次收录以来无变更记录
已变更无变更
FY2016
生效日期
- 首次收录
Elevated cancer antigen 125 [CA 125]
可用于账单的诊断编码
CDC/NCHS · FY2016所有版本 (19)
| 所有版本 | 生效日期 | 编码历史 |
|---|---|---|
| FY2016 | 2015-10-01 | 首次收录 |
| FY2017 | 2016-10-01 | 分类表无变更 |
| FY2018 | 2017-10-01 | 分类表无变更 |
| FY2019 | 2018-10-01 | 分类表无变更 |
| FY2020 | 2019-10-01 | 分类表无变更 |
| FY2020 · April | 2020-04-01 | 分类表无变更 |
| FY2021 | 2020-10-01 | 分类表无变更 |
| FY2021 · 01-01 | 2021-01-01 | 分类表无变更 |
| FY2022 | 2021-10-01 | 分类表无变更 |
| FY2022 · 04-01 | 2022-04-01 | 分类表无变更 |
| FY2023 | 2022-10-01 | 分类表无变更 |
| FY2023 · 04-01 | 2023-04-01 | 分类表无变更 |
| FY2024 | 2023-10-01 | 分类表无变更 |
| FY2024 · 04-01 | 2024-04-01 | 分类表无变更 |
| FY2025 | 2024-10-01 | 分类表无变更 |
| FY2025 · 04-01 | 2025-04-01 | 分类表无变更 |
| FY2026 | 2025-10-01 | 分类表无变更 |
| FY2026 · April | 2026-04-01 | 分类表无变更 |
| FY2027 | 2026-10-01 | 分类表无变更 |
历史 ICD-9 映射 · 2018
仅为历史映射,不可自动替换编码。
- 795.82
此条目是所选版本中的完整编码。 参考核验不能确定临床适用性,也不保证报销。